LUTONIX® Drug Coated Balloon LX3575780VRecalls & reported problems
Lutonix, Inc. · Lutonix 035 7X80MMX75CM · Class 3
All models of LUTONIX Drug Coated Balloon (107)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00801741187698), received between May 21, 2021 and Sep 8, 2025 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Detachment of Device or Device Component1
- Device-Device Incompatibility1
- Difficult to Insert1
- Material Rupture1
- Material Separation1
Patient problems
- Restenosis2
- Foreign Body In Patient1
- No Clinical Signs, Symptoms or Conditions1
- Stenosis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjurySep 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF THE STUDY (AV PAS) THAT SOMETIME LATER POST PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PROCEDURE BY USING LUTONIX DILATION CATHETER ON THE CEPHALIC VEIN OF THE LEFT UPPER ARM FOR DILATION OF STENOSIS, THE SUBJECT HAD STENOSIS ON THE TARGET VEIN. THE EVENT WAS NOT RELATED TO THE SUBJECT DEVICE OR PROCEDURE.
Patient problems: Restenosis; Stenosis
MAUDE report 22990261 ↗InjuryMay 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT APPROXIMATELY FIVE MONTHS AND TWENTY FOUR DAYS POST AN INDEX PROCEDURE USING A DRUG-COATED BALLOON CATHETER IN THE CEPHALIC VEIN STENOSIS, THE SUBJECT HAD AN ADVERSE EVENT OF CEPHALIC VEIN STENOSIS AND AV ACCESS CIRCUIT RE-INTERVENTION. REPORTEDLY, THE ADVERSE EVENT WAS NOT RELATED TO STUDY DEVICE AND PROCEDURE BUT DEFINITELY RELATED TO AV ACCESS CIRCUIT. A STANDARD PTA WAS USED IN RE-INTERVENTION ON TARGET LESION ON CEPHALIC VEIN WITH INITIAL STENOSIS OF 80% AND FINAL RESIDUAL STENOSIS OF 20%. REPORTEDLY, THE RE-INTERVENTION WAS SUCCESSFUL AND NO NEW ACCESS WAS CREATED. THE CURRENT STATUS OF THE PATIENT WAS UNKNOWN.
Patient problems: Restenosis
MAUDE report 22033296 ↗InjuryNov 12, 2021Material Rupture; Detachment of Device or Device Component; Material Rupture; Detachment of Device or Device Component
IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE IN THE ILIAC VESSEL, THE DRUG COATED BALLOON WAS ALLEGEDLY RUPTURED AT 6ATM. IT WAS FURTHER REPORTED THAT CATHETER HAD COMPLETELY BROKEN OFF AND WAS LOST INSIDE THE PATIENT. THE CURRENT PATIENT STATUS IS UNKNOWN.
Patient problems: Foreign Body In Patient
MAUDE report 12801697 ↗MalfunctionMay 21, 2021Difficult to Insert; Material Separation; Device-Device Incompatibility; Difficult to Insert; Material Separation; Device-Device Incompatibility
IT WAS REPORTED THAT DURING A PROCEDURE THROUGH THE UPPER ARM FISTULA TO TREAT STENOSIS THROUGH AN ANTEGRADE APPROACH, THE DEVICE ALLEGEDLY FAILED TO ADVANCE OVER THE GUIDEWIRE. IT WAS FURTHER REPORTED THAT THE DEVICE ALLEGEDLY DIFFICULT TO INSERT. THE PROCEDURE WAS COMPLETED BY USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11861555 ↗
Other Drug-coated peripheral transluminal angioplasty catheter devices
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575760VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter2 deaths60 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575860VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter3 deaths54 reports
- IN.PACT™ AV IAV06008008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter1 recall1 report
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX35751060VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter25 reports
- IN.PACT™ AV IAV08004008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter21 reports
- IN.PACT™ AV IAV08006008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter19 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575660VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter1 death19 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575840VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter17 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page